stocks logo

INO Financial Analysis

Inovio Pharmaceuticals Inc
$
1.580
+0.020(+1.280%)

INO Financial Analysis

FY2024Q4FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4FY2020Q3FY2020Q2FY2020Q1
Total Revenue
116.99K
13.97%
0.00
-100.00%
100.76K
-55.41%
0.00
-100.00%
102.65K
-17.66%
388.45K
-95.76%
225.97K
-71.19%
114.94K
-42.26%
124.67K
-85.14%
9.15M
3038.22%
784.40K
187.51%
199.07K
-46.36%
839.12K
-84.96%
291.70K
23.51%
272.82K
2.11%
371.12K
-72.04%
5.58M
1896.72%
236.18K
-72.75%
267.19K
96.93%
1.33M
Revenue from Goods & Services
0.00
0.00
0.00
0.00
-100.00%
0.00
0.00
0.00
-100.00%
114.94K
-42.26%
0.00
-100.00%
0.00
-100.00%
784.40K
187.51%
199.07K
-46.36%
839.12K
-84.96%
291.70K
23.51%
272.82K
2.11%
371.12K
-72.04%
5.58M
1896.72%
236.18K
-72.75%
267.19K
96.93%
1.33M
Gross Profit
0.00
-100.00%
0.00
-100.00%
100.76K
-55.41%
0.00
-100.00%
102.65K
-17.66%
388.45K
-95.76%
225.97K
-71.19%
114.94K
-42.26%
124.67K
-85.14%
9.15M
3038.22%
784.40K
187.51%
199.07K
-46.36%
839.12K
-84.96%
291.70K
23.51%
272.82K
2.11%
371.12K
-72.04%
5.58M
1896.72%
236.18K
-72.75%
267.19K
96.93%
1.33M
Selling General & Administrative Expenses
20.49M
-25.49%
27.35M
7.55%
33.30M
-5.58%
31.27M
-29.04%
27.50M
-50.96%
25.43M
-43.38%
35.27M
-66.39%
44.07M
-38.74%
56.07M
-47.28%
44.91M
-25.45%
104.92M
25.69%
71.93M
35.91%
106.35M
204.55%
60.24M
64.76%
83.47M
149.57%
52.93M
99.27%
34.92M
13.74%
36.57M
47.33%
33.45M
18.04%
26.56M
Research & Development Expense
12.89M
-25.31%
18.73M
20.84%
23.09M
6.19%
20.70M
-31.41%
17.25M
-59.04%
15.50M
-53.14%
21.74M
-61.49%
30.18M
-46.09%
42.12M
-54.37%
33.09M
-29.73%
56.46M
-20.26%
55.98M
43.37%
92.30M
250.91%
47.09M
77.99%
70.81M
216.44%
39.04M
104.30%
26.30M
19.54%
26.46M
38.24%
22.38M
-0.49%
19.11M
Operating Profit
-20.37M
-25.64%
-27.35M
9.22%
-33.20M
-5.26%
-31.27M
-28.85%
-27.39M
-51.04%
-25.04M
-29.97%
-35.04M
-66.35%
-43.95M
-38.73%
-55.95M
-46.97%
-35.76M
-40.36%
-104.14M
25.16%
-71.73M
36.49%
-105.51M
259.61%
-59.95M
65.03%
-83.20M
150.75%
-52.55M
108.28%
-29.34M
-3.56%
-36.33M
51.68%
-33.18M
17.66%
-25.23M
Financing Income- Net
852.59K
-44.52%
1.11M
-31.90%
1.31M
-29.51%
1.32M
-30.16%
1.54M
-2.44%
1.63M
54.45%
1.85M
240.83%
1.89M
431.45%
1.58M
275.83%
1.05M
262.98%
544.18K
17.94%
356.33K
39.08%
419.15K
-406.31%
289.90K
-126.66%
461.39K
-125.93%
256.20K
-110.73%
-136.84K
-93.42%
-1.09M
-39.30%
-1.78M
23.61%
-2.39M
Interest Expense
-852.59K
-44.52%
-1.11M
-31.90%
-1.31M
-29.51%
-1.32M
-30.16%
-1.54M
-2.44%
-1.63M
54.45%
-1.85M
240.83%
-1.89M
431.45%
-1.58M
275.83%
-1.05M
262.98%
-544.18K
17.94%
-356.33K
39.08%
-419.15K
-406.31%
-289.90K
-126.66%
-461.39K
-125.93%
-256.20K
-110.73%
136.84K
-93.42%
1.09M
-39.30%
1.78M
23.61%
2.39M
Sale of Tangible & Intangible Fixed Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Equity Earnings/(Loss) before Taxes
-1.03M
380.11%
324.25K
51.25%
-334.29K
-313.27%
-126.02K
-120.44%
-214.61K
74.70%
214.37K
-170.27%
156.75K
-116.78%
616.64K
-214.67%
-122.85K
-711.62%
-305.06K
1286.70%
-934.02K
-434.99%
-537.73K
-35.25%
20.09K
-93.44%
-22.00K
-100.08%
278.82K
-107.18%
-830.48K
-106.30%
306.32K
-118.22%
26.95M
-5647.47%
-3.88M
2141.86%
13.18M
Other Non-Operating Income
-1.91M
121.77%
-579.82K
-20416.01%
7.57K
-100.53%
-682.22K
-71.88%
-860.91K
-68.86%
2.85K
-100.30%
-1.43M
46746.03%
-2.43M
1480.57%
-2.76M
-1656.49%
-940.78K
3202.60%
-3.05K
-101.65%
-153.47K
-1809.38%
177.60K
1799.44%
-28.49K
-79.15%
185.28K
-221.81%
8.98K
-102.11%
9.35K
-96.45%
-136.64K
-196.94%
-152.10K
-219.28%
-425.50K
Income before Taxes
0.00
-100.00%
-25.17M
-25.83%
-32.24M
-9.28%
-30.47M
-25.04%
-25.00M
-54.09%
-33.93M
-10.20%
-35.53M
-67.25%
-40.65M
-47.15%
-54.46M
-49.07%
-37.78M
-37.20%
-108.50M
32.09%
-76.91M
42.51%
-106.95M
377.12%
-60.17M
-387.46%
-82.14M
-35.96%
-53.97M
62.87%
-22.42M
-41.38%
20.93M
-188.93%
-128.27M
332.09%
-33.14M
Income Taxes
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
0.00
-100.00%
0.00
Net Income after Tax
0.00
-100.00%
-25.17M
-25.83%
-32.24M
-9.28%
-30.47M
-25.04%
-25.00M
-54.09%
-33.93M
-10.20%
-35.53M
-67.25%
-40.65M
-47.15%
-54.46M
-49.07%
-37.78M
-37.20%
-108.50M
32.09%
-76.91M
42.51%
-106.95M
377.12%
-60.17M
-387.46%
-82.14M
-35.96%
-53.97M
62.87%
-22.42M
-41.24%
20.93M
-188.93%
-128.27M
333.65%
-33.14M
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
-469.41K
144.67%
-594.35K
Income Available to Common Shares
-19.38M
-22.48%
-25.17M
-25.83%
-32.24M
-9.28%
-30.47M
-25.04%
-25.00M
-54.09%
-33.93M
-10.20%
-35.53M
-67.25%
-40.65M
-48.59%
-54.46M
-49.07%
-37.78M
-37.20%
-108.50M
32.09%
-79.07M
45.35%
-106.95M
339.42%
-60.17M
-413.85%
-82.14M
-36.18%
-54.40M
67.18%
-24.34M
-35.38%
19.17M
-183.03%
-128.70M
337.96%
-32.54M
EPS - Basic
-0.65
-40.91%
-0.89
-41.45%
-1.19
-26.09%
-1.31
-30.69%
-1.10
-57.85%
-1.52
-16.48%
-1.61
-70.89%
-1.89
-56.35%
-2.61
-56.72%
-1.82
-46.94%
-5.53
17.66%
-4.33
34.06%
-6.03
261.08%
-3.43
-346.76%
-4.70
-52.57%
-3.23
3.19%
-1.67
-62.97%
1.39
-149.64%
-9.91
175.28%
-3.13
EPS - Diluted
-0.65
-40.91%
-0.89
-41.45%
-1.19
-26.09%
-1.31
-30.69%
-1.10
-57.85%
-1.52
-16.48%
-1.61
-70.89%
-1.89
-56.35%
-2.61
-56.72%
-1.82
-46.94%
-5.53
17.66%
-4.33
34.06%
-6.03
261.08%
-3.43
-359.85%
-4.70
-52.57%
-3.23
3.19%
-1.67
-62.97%
1.32
-147.14%
-9.91
175.28%
-3.13
EBIT
-20.37M
-25.64%
-27.35M
9.22%
-33.20M
-5.26%
-31.27M
-28.85%
-27.39M
-51.04%
-25.04M
-29.97%
-35.04M
-66.35%
-43.95M
-38.73%
-55.95M
-46.97%
-35.76M
-40.36%
-104.14M
25.16%
-71.73M
36.49%
-105.51M
259.61%
-59.95M
65.03%
-83.20M
150.75%
-52.55M
108.28%
-29.34M
-3.56%
-36.33M
51.68%
-33.18M
17.66%
-25.23M
EBITDA
0.00
-100.00%
-26.93M
10.37%
-32.71M
-4.58%
-30.85M
-28.54%
-26.82M
-51.18%
-24.40M
-29.75%
-34.27M
-66.75%
-43.16M
-38.93%
-54.95M
-47.39%
-34.73M
-41.23%
-103.07M
25.12%
-70.68M
36.56%
-104.44M
266.61%
-59.09M
66.57%
-82.37M
155.45%
-51.76M
113.11%
-28.49M
-2.67%
-35.48M
55.59%
-32.25M
19.42%
-24.29M
Depreciation Depletion & Amortization
0.00
-100.00%
419.31K
-34.62%
491.55K
-35.88%
424.47K
-46.23%
569.69K
-43.01%
641.31K
-37.54%
766.61K
-28.46%
789.46K
-25.27%
999.62K
-6.72%
1.03M
19.34%
1.07M
28.97%
1.06M
32.43%
1.07M
25.74%
860.30K
0.95%
830.90K
-11.16%
797.70K
-15.71%
852.26K
-26.14%
852.22K
-25.88%
935.27K
-21.99%
946.33K

INO FAQs

What is INO's PE Ratio in 2025/4/4?

INO's PE ratio in April 4, 2025 is -0.40. This indicates the price investors are willing to pay for $1 of earnings.

What is INO's PS Ratio in 2025/4/4?

What is INO's Dividend Yield in 2024/Q4?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is INO earnings result positive or negative?How should I trade on INO earnings?